Efficacy of Abemaciclib in the Management of Refractory Metastatic Extramammary Paget’s Disease

Published systemic therapy options for metastatic extramammary Paget's disease have largely been anecdotal due to the rarity of this disease, which has precluded the ability to conduct clinical trials. We describe the favorable response of a 72-year-old man with extramammary Paget's diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Gary W, Vetto, John, Leitenberger, Justin J, Hung, Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428388/
https://www.ncbi.nlm.nih.gov/pubmed/36060324
http://dx.doi.org/10.7759/cureus.27534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428388/
https://www.ncbi.nlm.nih.gov/pubmed/36060324
http://dx.doi.org/10.7759/cureus.27534

Ejemplares similares